When CRCs from two patient-derived xenografts and two CRC models grown directly from a biopsy of the oral tongue were exposed to the anti-ErbB3 antibody for six days, we observed a similar decrease in EGFR activity and increased expression of Trop2 (Fig. 3b). This evidence concerns the gene ERBB3 and colorectal carcinoma.